Parsons Capital Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-11,500
Closed -$56K 358
2018
Q2
$56K Hold
11,500
0.01% 352
2018
Q1
$49K Hold
11,500
0.01% 349
2017
Q4
$56K Hold
11,500
0.01% 358
2017
Q3
$50K Hold
11,500
0.01% 355
2017
Q2
$51K Hold
11,500
0.01% 348
2017
Q1
$48K Hold
11,500
0.01% 337
2016
Q4
$47K Buy
+11,500
New +$56K 0.01% 333

Other funds holding ASPN

Parsons Capital Management's ASPN Position: Q3 2018 in Review

Parsons Capital Management sold out of Aspen Aerogels (ASPN) in Q3 2018, closing a stake of 11,500 shares — an estimated $56K sold.

Parsons Capital Management first reported a position in ASPN in Q4 2016 and held it in 7 quarters. The position peaked at $56K in Q2 2018. 44 funds tracked by Wall St. Rank hold ASPN as of Q3 2018.

  • Parsons Capital Management reported no remaining Aspen Aerogels position as of Q3 2018 after selling out during the quarter.
  • Parsons Capital Management sold 11,500 Aspen Aerogels shares in Q3 2018, an estimated $56K.
  • Parsons Capital Management first reported a position in Aspen Aerogels in Q4 2016 and held it in 7 quarters.
  • Parsons Capital Management's Aspen Aerogels position peaked at $56K in Q2 2018.
  • 44 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2018.

Based on Parsons Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.